ST
This biopharmaceutical company develops cannabinoid active pharmaceutical ingredients (APIs) using hydrophilic conical structures that facilitate the internalization of cannabinoid molecules for neuroscience drug discovery. The company focuses on creating prescription medicines for patients with neurological diseases, leveraging its expertise in cannabinoid drug development to enhance treatment options.
Updated 3 months ago
Funding
$5.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This biopharmaceutical company develops cannabinoid active pharmaceutical ingredients (APIs) using hydrophilic conical structures that facilitate the internalization of cannabinoid molecules for neuroscience drug discovery. The company focuses on creating prescription medicines for patients with neurological diseases, leveraging its expertise in cannabinoid drug development to enhance treatment options.